BOULDER, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the second quarter ended June 30, 2023 and provided a corporate update “I am very pleased to announce another record-setting quarter from our core lung diagnostics,” said Scott Hutton, President and Chief Executive Officer. “In addition to continued sales growth, we had a number of important publi
Click here to view original post
News
Don’t Miss the Moments That Matter This Summer: Hearing Experts and Cochlear Encourage People to Check Their Hearing Health
Dr. Candice Colby‑Scott shares how cochlear implants can help people reconnect, and why thinking ahead about care, including MRI access, matters LONE TREE, Colo., June 26, 2026 /PRNewswire/ — Summer is a season for social […]
News
Espire Dental Acquires Southern Colorado-Based Anderson Family Dental
This marks the fast-growing integrated dental organization’s (IDO) seventh acquisition of 2023 COLORADO SPRINGS, Colo., May 4, 2023 /PRNewswire/ — Espire Dental, a fast-growing, elite, cosmetic and multi-specialty group practice, founded by dentists, is pleased […]
News
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
LOUISVILLE, Colo.–(BUSINESS WIRE)—- $BDSX #patientsfirst–Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced that new data will be presented today at the 2024 American Thoracic Society (ATS) International […]
